Drug Discovery World · Mar 2025
Summarizes the company’s GLP-1 sex-differences research and quotes CEO David Tingley on more personalized therapy design.
Combination therapeutics for the world's toughest diseases
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Olio Labs is a South San Francisco biotech company building AI/ML-driven combination therapeutics. Its core platform, the Combination Design Engine (CoDE), aims to identify multi-drug combinations that improve efficacy and reduce side effects, with public work focused on obesity and GLP-1 response differences.
Primary product
Combination Design Engine (CoDE) for AI-driven combination therapeutics
Founded
2023
Headquarters
South San Francisco, California, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
AI drug discovery / combination therapeutics
Offices
South San Francisco, California, United States (HQ)
Open Positions
0 jobs at Olio Labs
No open positions
Check back later for new openings